Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Pharmaceutical Research News Monitoring

Get by Email • RSS

Published on Jun 12, 2025

Governor Signs Ibogaine Treatment Research into Law

Governor Greg Abbott signed Senate Bill 2308 into law to grant state matching funds for research of ibogaine as an emerging treatment for neurological and mental health conditions during a bill signing ceremony at the Texas Capitol. Photo: Office of The …

Source: Mega Doctor News - Texas - Neutral
Published on Jun 14, 2025

Beet Juice Powers Heart Health and Endurance, Backed by Science

Once overlooked, beetroot juice is emerging as a natural powerhouse for lowering blood pressure, boosting stamina, and fighting inflammation. By yourNEWS Media Newsroom Beetroot juice, long considered a humble root remedy, is earning scientific respect as …

Source: [your]NEWS - Right-wing
Published on Jun 14, 2025

Hawthorn’s Healing Legacy: Ancient Symbol Emerges as Modern Heart Tonic

Clinical research affirms hawthorn’s traditional use as a cardioprotective herb rich in antioxidants, vasodilators and spiritual symbolism. By yourNEWS Media Newsroom For centuries, healers across cultures have turned to hawthorn — a unassuming yet potent …

Source: [your]NEWS - Right-wing
Published on Jun 12, 2025

University of Colorado Anschutz Medical Campus Receives $40M Gift for Eye Research

The Department of Ophthalmology at the University of Colorado Anschutz Medical Campus has received a $40 million philanthropic gift from an anonymous donor, a patient at the Sue Anschutz-Rodgers Eye Center. This contribution is among the most significant …

Source: Ophthalmology Breaking News - Neutral
Published on Jun 12, 2025

Align Technology awards funding to universities for advancing dental research

Align Technology has announced the award of twelve research grants to universities under the company’s fifteenth Annual Research Award Program. ‘Align is pleased to grant the following research awards that will lead to insights and evidence that advance …

Source: Dentistry.co.uk - Neutral
Published on Jun 12, 2025

Why Is Liminatus Pharma Inc (LIMN) Up 83%? Unpacking the Surge

The recent 82.81% surge in Liminatus Pharma Inc (LIMN) has captured the attention of investors across the biotech and pharmaceutical sectors. With shares closing at $20.31 on June 12, 2025, this dramatic price movement has prompted many to seek clarity on …

Source: Wealth Daily - Pending
Published on Jun 12, 2025

European Pharma Experts React to US Tariff Uncertainty

The Trump administration's threats of pharmaceutical import tariffs and most-favored-nation drug pricing have weighed heavily on the pharmaceutical industry in recent months. Alongside major changes to the US Food and Drug Administration, many are …

Source: Technology Networks - Neutral
Published on Jun 12, 2025

Regulating Hope: India’s ART Act, Global Best Practices, and the Drive for Research Excellence

Assisted Reproductive Technology (ART) has transformed fertility care, bringing renewed hope to countless individuals and couples facing infertility. In response to the growing demand and complexity of ART services, India introduced the Assisted …

Source: ETHealthworld.com - Center-right
Published on Jun 12, 2025

Your Pharmacist is an Essential Health Ally

When you think about your health care team, you likely think first about your doctors. Others, however, play a critical role in helping you stay healthy, including your pharmacist. This is especially true for older adults, according to Dr. Grant Tarbox, …

Source: Statesboro Herald - Georgia - Neutral
Published on Jun 12, 2025

Zopiclone Market Set to Witness Strong Growth, Reaching USD 2.5 Billion by 2033 | Sun Pharmaceutical Industries Ltd.

Zopiclone Market Research Report Information By Medicine Type, By Distribution Channel, And By Region CA, UNITED STATES, June 12, 2025 /⁨EINPresswire.com⁩/ -- Zopiclone Insights The Zopiclone Market was worth USD 1.5 billion in 2024 and is …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 12, 2025

Clamps Market Detailed in New Research Report, Expected to Cross USD 270.42 Million by 2032 | B. Braun Melsungen AG

Clamps Market Research Report Information By Product Type, By End User, And By Region FL, UNITED STATES, June 12, 2025 /⁨EINPresswire.com⁩/ -- Clamps Insights The Clamps Market is expected to expand its roots at a CAGR of 2.8% during 2022 to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 12, 2025

Obesity drug tops Finland’s pharmaceutical sales

A medication used to treat obesity and type 2 diabetes was the top-selling drug in Finland last year, according to new figures released by Kela. The active ingredient, semaglutide, saw its sales increase by nearly 30 percent in 2024. Semaglutide is …

Source: Helsinki Times - Indeterminate
Published on Jun 12, 2025

Policy changes and digital strategies guide oncology research

Against the backdrop of the recent US Food and Drug Administration’s (FDA) staff cuts and administrative realignment, understanding accelerated approval regulatory pathways, implementing pragmatic approaches and digital solutions is becoming more …

Source: Clinical Trials Arena - Pending
Published on Jun 14, 2025

Self-Collection May Help Increase Cervical Cancer Screening Rates

The addition of self-collection (SC) kits may help increase cervical cancer screening (CCS) rates vs telephone reminders (TR) alone, particularly among safety-net health settings and underserved populations who may experience structural barriers to clinic- …

Source: Cancer Network - New Jersey - Pending
Published on Jun 12, 2025

Market Trading Guide: Torrent Pharma and RHI Magnesita are stocks to buy on Friday. Potential upside up to 28%

Target: Rs 3,600-3,700 Stop loss: Rs 3,098 Torrent Pharma has taken support at its 200 EMA and witnessed bounce, indicating renewed buying interest. The surge in volume during today’s session reflects buyers' willingness to accumulate the stock as it …

Source: The Economic Times - Pending
Published on Jun 12, 2025

ONU Pharmacy Student Ruth Lim Receives National Public Health Award

Ohio Northern University Raabe College of Pharmacy student Ruth Lim has received a United States Public Health Service Excellence in Public Health Pharmacy Award. She was selected as one of the Top 10 recipients nationwide. The award recognizes pharmacy …

Source: WKTN - Ohio - Neutral
Published on Jun 12, 2025

Children's Research Institute Scientists Uncover Unique Pathway Tumors Use to Acquire Antioxidant Lipids

Newswise — DALLAS – June 11, 2025 – Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins – molecules that transport fat in blood – which enriches cancer cells with an antioxidant shield to survive stress, according to …

Source: Newswise - Neutral
Published on Jun 12, 2025

From well-being to white replacement: What psychology research says about immigration

Immigration is one of the most debated issues in many countries, often sparking strong opinions about its social, economic, and political consequences. But what does the research actually show? From mental health outcomes to attitudes shaped by uncertainty …

Source: PsyPost - Neutral
Published on Jun 12, 2025

New Research Reveals How Childhood Trauma Fuels Substance Use Disorders in Men

10 Reading Time: 2 minutesA growing body of research compiled by The Last Resort Recovery Center reveals a strong link between childhood trauma and substance use disorders (SUDs) in men. Emotional and physical abuse, neglect, and other early adverse …

Source: Psychreg - Pending

16 days 16:53:15

Featured Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:33 GMT

WST 重要截止日期：全美審訊法律顧問 ROSEN 鼓勵損失 10 萬美元以上的 West Pharmaceutical Services, Inc. 投資者在對 WST 提出證券集體訴訟的重要截止日期前聘請律師

紐約, June 15, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2023 年 2 月 16 日至 2025 年 2 月 12 日（包括首尾兩日，下稱「集體訴訟期」）期間購買了 West Pharmaceutical Services, Inc. (NYSE: WST) 普通股之人士注意，重要的首席原告截止日期為 2025 年 7 月 7 日。影響：如果您在集體訴訟期間購買 West …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 14:00 GMT

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...

Published on June 15, 2025 - 14:33 GMT

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with ...

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 822,448,879 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 15, 2025 - 12:13 GMT

Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21

Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- In a time when public health and …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 15, 2025 - 12:06 GMT

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights

Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Mucopolysaccharidosis type I (MPS I) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:06 GMT

Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly

New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Hunter Syndrome ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 04:30 GMT

Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser

ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /⁨EINPresswire.com⁩/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 15:22 GMT

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:22 GMT

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 15:21 GMT

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 15, 2025 - 03:00 GMT

Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices

New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Tom Jackobs, international sales strategist, is now offering …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 15, 2025 - 14:45 GMT

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in ...

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 15, 2025 - 12:00 GMT

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

RCP statement on Air India crash

RCP president, Dr Mumtaz Patel, said: ‘We are devastated by the plane crash in India today and the many lives it has claimed. Our thoughts and prayers are with everyone affected by this tragic incident. ‘We are directly contacting all our RCP members in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 12:00 GMT

Latest ‘Focus on physicians’ survey closes with over 2000 responses from doctors across the UK

The 2025 ‘Focus on physicians’ survey – a joint project between the Royal College of Physicians (RCP), the Royal College of Physicians and Surgeons of Glasgow (RCPSG) and the Royal College of Physicians of Edinburgh (RCPE) – has now closed. The ‘Focus on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 15, 2025 - 11:45 GMT

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 15, 2025 - 11:11 GMT

D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth

Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced athletic performance and muscle growth, many fitness enthusiasts and bodybuilders turn to supplements. D-Bal Max has emerged as a noteworthy option that claims to replicate the muscle- …

Distribution channels:
Published on June 14, 2025 - 16:42 GMT

Blue Sky Scrubs Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet

Blue Sky Medical Scrubs and Scrub Caps Celebrates World Wind Day: Championing Clean Energy for a Healthier Planet AUSTIN, TX, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- In celebration of World Wind Day, Blue Sky Scrubs proudly joins the …

Distribution channels: Culture, Society & Lifestyle, Environment ...
Published on June 14, 2025 - 16:38 GMT

Cherry Blossoms and The Other Side, A Poetic Journey Through Grief and Beyond

LAWRENCE, MA, UNITED STATES, June 14, 2025 /⁨EINPresswire.com⁩/ -- Acclaimed writer and visual dramatist Dennis Mullings presents a powerful double release with Cherry Blossoms and The Other Side, two moving and visually arresting plays that navigate the …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on June 14, 2025 - 16:28 GMT

ICN elects new President, José Luis Cobos Serrano and a new Board of Directors

ICN announces Dr José Luis Cobos Serrano as its 30th President at its Congress in Helsinki HELSINKI, FINLAND, June 14, 2025 /⁨EINPresswire.com⁩/ -- At the closing ceremony of ICN Congress 2025, ICN announced that it has elected Dr José Luis Cobos …

Distribution channels: Healthcare & Pharmaceuticals Industry, Human Rights ...
Published on June 14, 2025 - 14:48 GMT

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in ...

77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week 52 Data further support barzolvolimab clinical benefit to patients with CSU HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 14, 2025 - 14:42 GMT

ThinkCareBelieve: Week 21 of America's Progress under President Trump

Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here: https://thinkcarebelieve.blog/2025/06/14/week-21-of-americas-progress-under-president-trump/ ThinkCareBelieve has published an article on the …

Distribution channels: Book Publishing Industry, Healthcare & Pharmaceuticals Industry ...